Matt Henriksen

in an easier way than kind of maybe a fully disposable patch pump?

Yeah.

And so the other thing too, is because you're using the same algorithm, that kind of, you don't need to, do you need to have a new trial to support the durable, the, the, the, the on the body wear pump, or is it, are you able to go to the FDA and say, look,

We already have the algorithm.

We have this new pump that checks off the boxes compared to some of the other on the body wares that are in the market.

We don't need to have that new clinical trial.

We got a lot of alphabet soup right now going on, but yeah.

No worries.

All right.

So what is then the potential timeline to get Mint to the market?

Okay.

All right.

That's good to know.

And we'll mark that on the calendar.

So next time we probably have you next year, we'll get a good update on how things are going.

Yeah.

And so, you know.

The other thing, you know, kind of longer-term project you have, and it kind of goes back to the beginning of Beta Bionics and, you know, hearing the story from Ed about, you know, his reasons for starting, you know, the company because, you know, making sure to take care of his children who were suffering from the disease.

It always started as a dual hormone company.

And so now we're kind of getting to that, you know, potentially that full circle of getting back to a dual hormone company.